GENETIC POLYMORPHISMS IN SLCO1B1 ARE NOT ASSOCIATED WITH ALTERED VOXILAPREVIR EXPOSURE.

被引：0
|
作者：
Garrison, K. [1 ]
Song, Q. [1 ]
Stamm, L. [1 ]
Ling, J. [1 ]
Mathias, A. [1 ]
机构：
[1] Gilead Sci, Foster City, CA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-073
引用
收藏
页码：S34 / S34
页数：1
相关论文
共 50 条
  • [1] SLCO1B1 polymorphisms and lopinavir plasma concentrations
    Kohlrausch, F. B.
    Estrela, R. de Cassia
    Barroso, P. F.
    Suarez-Kurtz, G.
    PHARMACOGENOMICS, 2010, 11 (07) : 917 - 918
  • [2] SLCO1B1 Polymorphisms are Associated with the Susceptibility to Pulmonary Tuberculosis in Chinese Females
    Wei Li
    Wei Liu
    Xiong Wang
    Rui Dou
    Zunmin Zhu
    Biochemical Genetics, 2024, 62 : 385 - 394
  • [3] Effects of SLCO1B1 and SLCO1B3 Genetic Polymorphisms on Valsartan Pharmacokinetics in Healthy Korean Volunteers
    Song, Gonjin
    Chung, Jee-Eun
    Yee, Jeong
    Lee, Kyung-Eun
    Park, Kyungsoo
    Gwak, Hye-Sun
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (09):
  • [4] SLCO1B1 Polymorphisms are Associated with the Susceptibility to Pulmonary Tuberculosis in Chinese Females
    Li, Wei
    Liu, Wei
    Wang, Xiong
    Dou, Rui
    Zhu, Zunmin
    BIOCHEMICAL GENETICS, 2024, 62 (01) : 385 - 394
  • [5] GLOBAL ANALYSIS OF GENETIC VARIATION IN SLCO1B1
    Pasanen, Marja K.
    Neuvonen, Pertti J.
    Niemi, Mikko
    DRUG METABOLISM REVIEWS, 2008, 40 : 136 - 137
  • [6] SLCO1B1 Polymorphisms are Associated With Drug Intolerance in Childhood Leukemia Maintenance Therapy
    Eldem, Irem
    Yavuz, Duygu
    Cumaogullari, Ozge
    Ileri, Talia
    Ince, Elif Unal
    Ertem, Mehmet
    Erdogan, Beyza Doganay
    Bindak, Recep
    Ozdag, Hilal
    Satiroglu-Tufan, N. Lale
    Uysal, L. Zumrut
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (05) : E289 - E294
  • [7] SLCO1B1, SLCO2B1, and SLCO1B3 Polymorphisms and Susceptibility to Bladder Cancer Risk
    Hoai Thi Thu Bui
    Fujimoto, Naohiro
    Kubo, Tatsuhiko
    Inatomi, Hisato
    Matsumoto, Tetsuro
    CANCER INVESTIGATION, 2014, 32 (06) : 256 - 261
  • [8] Impact of SLCO1B1 Genetic Variation on Rosuvastatin Systemic Exposure in Pediatric Hypercholesterolemia
    Wagner, Jonathan B.
    Abdel-Rahman, Susan
    Gaedigk, Andrea
    Gaedigk, Roger
    Raghuveer, Geetha
    Staggs, Vincent S.
    Van Haandel, Leon
    Leeder, J. Steven
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (03): : 628 - 637
  • [9] An integrated pharmacokinetic/pharmacogenomic analysis of ABCB1 and SLCO1B1 polymorphisms on edoxaban exposure
    A G Vandell
    J Lee
    M Shi
    I Rubets
    K S Brown
    J R Walker
    The Pharmacogenomics Journal, 2018, 18 : 153 - 159
  • [10] An integrated pharmacokinetic/pharmacogenomic analysis of ABCB1 and SLCO1B1 polymorphisms on edoxaban exposure
    Vandell, A. G.
    Lee, J.
    Shi, M.
    Rubets, I.
    Brown, K. S.
    Walker, J. R.
    PHARMACOGENOMICS JOURNAL, 2018, 18 (01): : 153 - 159
12345